MétaCan
Menu
Back to cohort
Record W4416140055 · doi:10.1093/neuonc/noaf201.1825

TMIC-70. Integrative spatiotemporal proteomic and metabolomic characterization of immune infiltration following intracranial injection of oncolytic immunotherapy in glioblastoma patients

2025· article· en· W4416140055 on OpenAlexaff
Jennifer Gantchev, Gerard Baquer, Alicia D. D’Souza, Alexander Ling, Michael S. Regan, G B M TeamLab, Atul Deshpande, Forest M. White, Kenny Yu, E Antonio Chiocca, Charles Couturier, Nathalie Y.R. Agar

Bibliographic record

VenueNeuro-Oncology · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer Research and Treatments
Canadian institutionsMcGill University
Fundersnot available
KeywordsOncolytic virusImmune systemCytotoxic T cellImmunotherapyTumor microenvironmentCD8ProteomicsMetabolomics

Abstract

fetched live from OpenAlex

Abstract Glioblastoma (GBM) is the most aggressive and lethal primary brain tumor in adults, characterized by rapid proliferation, an immunologically inert microenvironment, diffuse tumor cell infiltration and therapy resistance. Progress in developing effective glioblastoma treatments is impeded by a lack of mechanistic insight into how GBM cells and the surrounding microenvironment respond to therapeutic interventions. To address this prominent gap, we developed an innovative on-therapy, longitudinal, and multi-regional tissue sampling approach in patients receiving rQNestin34.5v.2, an engineered oncolytic biologic, based on herpes simplex virus 1, to investigate the dynamic evolution of tumor and immune ecosystems during treatment. Using targeted spatial proteomics (CyCIF) alongside spatial metabolomics (MALDI-MSI), we analyzed over 100 samples from six patients, profiling immune, stromal, and malignant cells across both space and time. Our CyCIF data revealed that T and B cells infiltrate and colocalize within rQnestin34.5v.2–positive regions, forming clusters that reflect active immune interactions. These immune-rich zones were inversely correlated with SOX2⁺ and OLIG2⁺ tumor cells. Notably, patients with longer survival showed a progressive increase in CD3⁺ T cells, driven by expanding cytotoxic T cell populations alongside a reduction in CD4⁺ T cells. Despite increased immune infiltration, post-trial tissues displayed an immunosuppressive environment characterized by few cytotoxic T cells and reduced tumor cells. Integrating spatial proteomics and metabolomics, we observed elevated purine metabolites—including ATP, GTP, and xanthine—in regions of heightened immune infiltration. Extracellular ATP and GTP likely facilitate T cell activation and migration through purinergic signaling and GTPase pathways. These metabolic patterns suggest that purine metabolism plays a key role in shaping immunologically active tumor microenvironments following treatment. Together, these findings provide novel mechanistic insights into the evolving tumor-immune landscape during rQnestin34.5v.2 therapy in glioblastoma, highlighting purine metabolism as a potential driver of immune activation within the tumor microenvironment. This integrated spatial approach offers a powerful framework to guide the development of more effective immunotherapeutic strategies for this challenging malignancy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.005
GPT teacher head0.278
Teacher spread0.273 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicCancer Research and TreatmentsFrench-language works237,207